Trial Search Results

Cyberknife Radiosurgery and Quality of Life

The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.

   - There are no age or gender restrictions.

   - There are no life expectancy restrictions.

   - Karnofsky Performance Status greater than 40.

   - Negative pregnancy test or clinically assessed as not pregnant.

   - Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

   - Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)

   - Other investigational medications or treatments will be noted, but will not preclude
   inclusion.

   - Pregnant or nursing patients will be not be included in the study due to radiation
   exposure.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
ccto-office@stanford.edu
650-498-7061